StockDuty ← Dashboard Aug 12, 2026 11:50 AM ET
CatalystFDA/Bio

PROTAGONIST THERAPEUTICS: "STRONG BUY" ICOTYDE FDA APPROVAL AND PN-881 ADVANCEMENT - SEEKINGALPHA

FDA approval of Icotype and PN-881 advancement

What changed
FDA approval of Icotype and PN-881 advancement
Why it matters
FDA approval of Icotype and PN-881 advancement — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →